JPRN-C000000052已完成未知
Phase-I/IIa study of radiofrequency ablation combined with in situ application of immune adjuvant for hepatocellular carcinoma - RFA+ISAIA
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Immunodeficiency
研究者
相似试验
已完成
不适用
Phase-I/IIa study of radiofrequency ablation combined with in situ application of immunoadjuvant, Cal-TUMPHepatocellular carcinomaJPRN-UMIN000000767Kanazawa university16
已完成
2 期
Phase II study on radiofrequency ablation in early breast cancerbreast cancerJPRN-UMIN000020805Department of Breast Surgery, School of Medicine Kyorin University29
招募中
2 期
Phase II study on radiofrequency ablation in stage 0 and I breast cancer without extensive intraductal componentsbreast cancerJPRN-UMIN000013836Department of Breast Surgery, School of Medicine Kyorin University32
招募中
不适用
Prospective evaluation of radiofrequency ablation for benign biliary stricturesBenign biliary strictureJPRN-UMIN000040155Aichi Medical University20
招募中
不适用
Prospective evaluation of radiofrequency ablation for refractory benign pancreatic duct stricturesrefractory benign pancreatic duct strictureJPRN-UMIN000040098Aichi Medical University20